Lao Saal
banner
laosaal.bsky.social
Lao Saal
@laosaal.bsky.social
MD PhD, cancer researcher, assoc. professor @ Lund University. Founder @ SAGA Diagnostics. Medical Dir. @ DoMore Diagnostics. Interested in PTEN/PI3K, liquid biopsies, AI/ML and the application of novel omics-based tools in cancer care.
✅ Interested in the latest in #cancer #liquidbiopsy, circulating tumor DNA ( #ctDNA), and #MRD testing? 🧪

I'll be a #panelist on a virtual #roundtable on October 22nd.

Signup below. Hosted by @genomeweb.bsky.social

event.on24.com/wcc/r/508470...

#oncology #bcsm #cancerdiagnostics #dPCR
Virtual Roundtable: Evolving Technologies for Molecular Residual Disease Testing in Solid Tumors, Perspectives on Platforms and Clinical Utility
Wednesday, October 22, 2025 at 12:00 PM Eastern Daylight Time.
event.on24.com
October 13, 2025 at 1:31 PM
Very nice #SABCS spotlight poster session on #ctDNA (moderated by Chuck Perou) where 2 abstracts were highlighted showing the leading performance of SAGA’s structural variant-based #MRD assay in #breastcancer.
December 12, 2024 at 4:48 PM
Looking forward to seeing the latest advances in breast cancer research at #SABCS!
We are looking forward to this year's San Antonio Breast Cancer Symposium which starts on December 10. Take a look at the full program for this important meeting featuring the latest research on breast cancer. sabcs.org/FullProgram #SABCS24 #breastcancer
November 30, 2024 at 3:07 PM
Seems like the party’s moved over here now …

🧬🔬⚗️🔭🥼🧪👩🏽‍🔬🧑🏽‍💻👨‍🔬👨🏿‍💻
November 17, 2024 at 10:25 AM
Our new publication online today on dPCR quantification of “#ultrahigh” #HER2 #ERBB2 copy number in early #breastcancer and association to poor response to #trastuzumab. Nice work by #pei_meng #heena_dilal @brueffer.io #sergii_gladchuk #anna_ehinger et al www.nature.com/articles/s41...
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab - npj Breast Cancer
npj Breast Cancer - Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
www.nature.com
February 19, 2024 at 9:39 PM
A new year. Nice to receive a message with the first manuscript accepted for publication in 2024! 🥳

Congrats to the team @brueffer.io @meng_pei36787 @HeenaBioinfo YChen @SergiiGladchuk @malcaidesg @ehinger_anna
January 29, 2024 at 11:31 AM